Figure 4. PEDF effects on CRX in the nuclei of photoreceptors undergoing zaprinast-induced degeneration. A: Schematic illustration of the treatment protocol of wild-type mouse retinal explants without or with 20 nM PEDF[H105A] protein,
followed by 100 μM zaprinast addition. B: Representative confocal microscopy images of retinal explants showing CRX immunofluorescence staining (green) and DAPI staining
of photoreceptor nuclei (pseudo-gray). Retinas were treated with vehicle (equivalent volumes of DMSO and PBS), PEDF[H105A]
(20 nM), and zaprinast (100 µM). Data are representative of four biological replicates (n = 4 eyes) with four technical replicates
(ROIs per eye) per condition. Mice were 3 months old. C: CRX mean fluorescence intensity (MFI) was measured within each ROI and normalized to the number of DAPI-positive nuclei;
each point represents one explant from one of three independent mice (n = 3). Data are shown as mean ± SD. Statistical significance
was determined by ordinary one-way analysis of variance multiple comparisons: ns, not significant; *p < 0.05.
